Thank you for registering your interest in our COVID-19 vaccine study. Recruitment has now closed. To register for further COVID studies in the future, please visit usc.edu.au/trials.
What is the study for?
This study is assessing the safety and efficacy (how well it works) of a potential vaccine for Coronavirus (SARS-CoV-2), and determining the best dose for optimal immune response to the vaccine.
The study is a combined Phase I and II clinical trial, however USC Clinical Trials is participating in the Phase II portion of the study.
- 6 visits to our Sippy Downs centre over an approximately 7.5 month period
- 3 vaccinations spread over this time
- 2 follow-up phone calls about 2 months and 4.5 months after the last study visit
Vaccinations are given intramuscularly, similar to a flu shot.
This is a placebo controlled and blinded study, which means you won't know whether you receive the vaccine or placebo.
The research team will sit down with you and go through the study criteria, as well as your medical history, current and past medications and vaccinations. There will be some blood tests and medical examinations to help determine your eligibility for the study.
You will be required to present a valid form of ID at each visit.
All study procedures are at no cost to you, and you will be compensated for your time and travel expenses.
Where can I find more information?
More information can be requested by contacting the research site to the right. Alternatively, the research team will be more than happy to answer any questions you may have when they call.
You can also find more study information on the clinical trials database, ClinicalTrials.gov
HREC approval: Alfred Hospital Ethics Committee